Novorapid 100 is a rapid-acting Insulin analog used to treat Diabetes Mellitus in adults and children. Its primary ingredient is Insulin Aspart, a modified form of human Insulin that acts more quickly than regular human Insulin.
Novorapid works by helping your body use glucose properly, preventing blood sugar levels from getting too high. It begins working within 10-20 minutes after injection, peaks in 1-3 hours, and lasts for 3-5 hours.
Common side effects include Hypoglycemia, injection site reactions, and allergic reactions.
Novo Nordisk India Pvt Ltd is the manufacturer of Novorapid. The medication should be stored in a refrigerator (2°C-8°C) before first use and can be kept at room temperature (below 30°C) for about 4 weeks after opening.
Protect from direct heat and light, and never freeze the solution.
Novorapid 100 IU mimics the natural Insulin spike that occurs in people without Diabetes when they eat. Its rapid onset allows it to be injected right before or shortly after meals, providing greater flexibility than traditional Insulin formulations.
The rapid action of Insulin Aspart helps to:
It is crucial to note that Novorapid must be part of a comprehensive Diabetes treatment plan that may include diet, exercise, and other medications.
Novorapid 100 is a prescription medication that should be taken per your doctor's instructions. Here are the general guidelines:
The strengths and substitutes available for Novorapid solution at Cheap Medicine Shop are:
| $36.25 | |
| $36.19 |
Novorapid 100 IU is generally well-tolerated when used correctly. However, it may cause side effects, including:
These adverse effects typically can be managed with proper technique and monitoring. Severe Hypoglycemia requires immediate medical attention.
Liver disease
Patients with liver impairment may have reduced Insulin requirements. Frequent blood glucose monitoring is recommended, and dose adjustments may be necessary. Consult your healthcare provider for personalized guidance.
Kidney impairment
Kidney disease can affect Insulin clearance and may reduce Insulin requirements. Patients with renal impairment should monitor blood glucose levels closely and may need dosage adjustments under medical supervision.
Pregnant and breastfeeding women
Novorapid can be used during pregnancy and while breastfeeding. Tight blood glucose control is especially important during pregnancy to reduce risks to both mother and baby. Insulin requirements typically increase during pregnancy, particularly in the second and third trimesters. Regular monitoring and consultation with doctors is essential.
Avoid
Alcohol consumption may increase the risk of Hypoglycemia and can unpredictably affect blood glucose levels. Exercise caution with certain medications like beta-blockers, which may mask Hypoglycemia symptoms. Avoid changing injection techniques or Insulin types without medical supervision.
Yes, Novorapid can be mixed with NPH Insulin, but it should be drawn into the syringe first. Do not mix with other Insulin analogs or preparations unless specifically advised by your doctor.
Monitor your blood glucose level and adjust the next dose accordingly. Do not double-dose to make up for missed doses. Consult the healthcare professional for personalized advice on managing missed doses.
Novorapid begins lowering blood glucose within 10-20 minutes after injection. It reaches maximum effect between 1-3 hours and has a duration of action of 3-5 hours. However, individual responses may differ.
After first use, Novorapid can be stored at room temperature (below 30°C) for up to 4 weeks. Never freeze Insulin and keep it away from direct heat and sunlight. Follow the instructions on the packaging.
Watch for shakiness, dizziness, sweating, hunger, headache, irritability, rapid heartbeat, confusion, and, in some severe cases, loss of consciousness. Always carry fast-acting carbohydrates to treat low blood sugar. Ask a doctor for more safety information.